MENU

Electromedicine: Rife

While most people have a general idea about what nutritional protocols do for cancer patients, they have no clue what “electromedicine” devices are designed to do.

Electromedicine devices fall into one of three categories based on popular alternative oncology theories:

1) They are designed to kill microbes in the bloodstream, lymph system, etc.

2) They are designed to kill microbes which are inside the cancer cells.

3) They are designed to kill microbes and parasites in the organs to energize organs and the immune system to deal with the “root cause” of the cancer.

Dr. Royal Rife, a microbiologist, designed his device to kill microbes which were inside of the cancer cells. That is why his device had a “carrier frequency.”His theory was that if you can kill all of the microbes inside the cancer cells, then they will be able to restore their metabolism and will revert into normal cells.

High RF Frequency Devices (Plasma and Pad)

Theory behind the device: Because of these original machines, the Rife's two methods which used either “High Frequencies” or “Low Audio Frequencies” matched to a specific carrier wave. Using frequency generating equipment which uses either electrodes (e.g. High RF Frequency Device – 15 Watt) or the plasma amplifier (e.g. High RF Frequency Device – Plasma), Rife's original frequencies can now be used by those who want to use the Rife method.

The Bob Beck Protocol

Another “electromedicine” protocol is the Bob Beck protocol. The Bob Beck machines claim to kill the microbes in the bloodstream, lymph system and elsewhere in the body (but not inside the cancer cells). By doing this the immune system is said to be supercharged able to safely kill the cancer cells.

Clinics that offer
Electromedicine

Cancer Tutor Verified

Clinics

ADDITIONAL TOPICS

References

  1. Irreversible electroporation (NanoKnife) in cancer treatment | A.Tafti Stephen T.Kee Edward W.Lee | Interventional Radiology, Department of Radiology, Ronald Reagan Medical Center at UCLA, David Geffen School of Medicine, Los Angeles, CA, USA | Received 23 September 2013, Revised 24 February 2014, Accepted 27 February 2014, Available online 15 March 2014. https://www.sciencedirect.com/science/article/pii/S2213179514000078
  2. Guest Commentary: Update on use of irreversible electroporation for locally advanced pancreatic cancer | Marcovalerio Melis, MD, FACS | Healio | February 3, 2016 https://www.healio.com/gastroenterology/oncology/news/online/%7B6bf63dbe-3467-4522-acfe-7eb110a1e7aa%7D/guest-commentary-update-on-use-of-irreversible-electroporation-for-locally-advanced-pancreatic-cancer
  3. A Potential Boon for Pancreatic Cancer Patients | Johns Hopkins Medicine | June 23, 2014 https://www.hopkinsmedicine.org/news/publications/johns_hopkins_surgery/johns_hopkins_surgery_summer_2014/a_potential_boon_for_pancreatic_cancer_patients
  4. Irreversible Electroporation versus Radiofrequency Ablation: A Comparison of Local and Systemic Effects in a Small-Animal Model | Baruch E. Bulvik, PhD, Nir Rozenblum, PhD, Svetlana Gourevich, BSc, Muneeb Ahmed, MD, Alexander V. Andriyanov, MSc, Eithan Galun, MD, S. Nahum Goldberg, MD | RSNA Radiology, August 2016; Volume 280, Issue 2 | https://doi.org/10.1148/radiol.2015151166
  5. Nearly 1,000 cancer drugs in development in USA | Kevin Grogan | PharmaTimes online | June 1, 2012 | http://www.pharmatimes.com/news/nearly_1%2C000_cancer_drugs_in_development_in_usa_977219